Untranslated regions (UTRs) are a potential novel source of neoantigens for personalised immunotherapyImmunology Original Research Published on 2024-03-152024-09-05 Journal: Frontiers in immunology [Category] update2024, [키워드] Checkpoint inhibitor immunopeptidomics neoantigen personalised vaccine PrimeCUTR untranslated region UTR [DOI] 10.3389/fimmu.2024.1347542 PMC 바로가기 [Article Type] Immunology Original Research
Cognitive adverse events in patients with lung cancer treated with checkpoint inhibitor monotherapy: a propensity score-matched analysisArticle Published on 2023-04-272024-09-05 Journal: EClinicalMedicine [Category] update2024, [키워드] Checkpoint inhibitor Cognitive adverse events immune-related adverse events Minimal clinically important difference propensity score matching [DOI] 10.1016/j.eclinm.2023.101987 PMC 바로가기 [Article Type] Article
Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case reportArticle Published on 2022-10-312022-11-15 Journal: Journal of Medical Case Reports [Category] 진단, [키워드] Administered Advanced basal cell carcinoma atezolizumab bladder Bladder cancer Cancer cancers carried Case report Cell Checkpoint inhibitor chemotherapeutic agent clinician Comorbidity Complete Compliance complication of COVID-19 cumulative Definitive disease dose female histology hospital increasingly indicated Infection inhibitor knowledge lymph nodes Metastasis metastatic Metastatic muscle-invasive bladder cancer Patient PD-L1 PD-L1 inhibitor. positive progressed Radiotherapy reached receiving Side effects smoking synchronous the patient therapy transurethral resection treated Treatment tumors [DOI] 10.1186/s13256-022-03634-x PMC 바로가기
Does immune checkpoint inhibitor increase the risks of poor outcomes in COVID-19-infected cancer patients? A systematic review and meta-analysisMeta-Analysis Published on 2022-02-012023-07-06 Journal: Cancer immunology, immunotherapy : CII [Category] COVID19(2023년), [키워드] Checkpoint inhibitor COVID-19 Neoplasms Prognosis Programmed cell death 1 receptor. [DOI] 10.1007/s00262-021-02990-9 PMC 바로가기 [Article Type] Meta-Analysis
Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitorsOriginal Research Published on 2021-07-292024-09-04 Journal: Translational Oncology [Category] 대상포진, [키워드] BRD4 BRD4-NUT Checkpoint inhibitor NUT carcinoma NUT midline carcinoma PD-L1 [DOI] 10.1016/j.tranon.2021.101184 PMC 바로가기 [Article Type] Original Research
Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint MattersReview Published on 2021-07-212023-08-30 Journal: Frontiers in Immunology [Category] E형 간염, [키워드] Checkpoint inhibitor hyperprogression Immunotherapy resistance Tertiary lymphoid structures [DOI] 10.3389/fimmu.2021.690112 PMC 바로가기 [Article Type] Review
Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma PatientsArticle Published on 2021-05-182024-09-02 Journal: Cancers [Category] 대상포진, [키워드] CD38 Checkpoint inhibitor daratumumab durvalumab Immunotherapy Multiple myeloma PD-L1 [DOI] 10.3390/cancers13102452 PMC 바로가기 [Article Type] Article
Characteristics and risk factors for microbial infections during cancer immune checkpoint therapyOriginal Research Published on 2020-11-072024-09-02 Journal: Cancer Medicine [Category] 대상포진, [키워드] Cancer Checkpoint inhibitor Immunotherapy Infection microbes [DOI] 10.1002/cam4.3532 PMC 바로가기 [Article Type] Original Research
Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and OpportunitiesReview Published on 2020-11-052023-08-30 Journal: Frontiers in Immunology [Category] E형 간염, [키워드] Angiogenesis Checkpoint inhibitor programmed death ligand 1 (PD-L1) programmed death-1 (PD-1) tumor microenvironment vascular endothelial growth factor (VEGF) [DOI] 10.3389/fimmu.2020.598877 PMC 바로가기 [Article Type] Review
The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidenceReview Published on 2020-06-012023-06-13 Journal: Cancer treatment reviews [Category] B형 간염, [키워드] Cancer Checkpoint inhibitor Chronic viral infection CTLA-4 hepatitis B hepatitis C HIV Immunotherapy PD-1 PD-L1 Reactivation [DOI] 10.1016/j.ctrv.2020.102011 [Article Type] Review